G-Protein Coupled Receptors Market Explores Lucrative Prospects in North America, Global Market to Exhibit 8.80% CAGR till 2022:

Albany – NY, Oct. 20, 2015 (GLOBE NEWSWIRE) — Transparency Market Research has recently published a report, which gives insights into the growth drivers, key restraints, and potential opportunities of the global G-protein coupled receptors (GPCRs) market. The report is titled “G-Protein Coupled Receptors (GPCRs) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022” and is available on the company website for sale.

Browse the full G-Protein Coupled Receptors (GPCRs) Market (Assay Type: cAMP Assays, Calcium Level Detection Assays, GTPγS Binding Assays, Reporter Gene Assays, Receptor Internalization Assays, and cGMP Assays; Therapeutic Areas: Cardiovascular System, Central Nervous System, Respiratory System, Immune System, Reproductive System, Oncology, and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022 report at http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html

According to the findings of the report, the global G-protein coupled receptors market stood at US$1.6 bn in 2013 and it estimated to reach US$3.5 bn by the end of 2022. If the figures hold true, the market will register a positive CAGR of 8.80% during the 2014-2022 period.

GPCRs belong to the family of cell surface receptors that respond to wide-ranging external stimuli and play a key role in contemporary pharmacology owing to their indispensable role in cell communication. The majority of the drugs discovered and 30% of those available in the market as well as those under development process target GPCRs. The report states that the development of novel therapeutics is largely attributed to the rising demand for treatment of pain, inflammation, and other neurobiological disorders. Compounds targeting GPCRs are also used in the food and cosmetics markets to modulate the taste and smell of the product. Accelerating demand for GPCR assays, particularly in drug development activities and due to the increasing incidence of respiratory, reproductive, nervous system disorders, various cancers, and cardiovascular disorders worldwide is a key factor steering the global GPCRs market. 

The global GPCRs market includes calcium level detection assays such as GTPγS binding assays, cAMP, reporter gene, receptor internalization, and cGMP assays. Of these, the cAMP assays segment held the largest share in the market, accounting for 32.5% in 2013. However, in terms of growth, this segment is likely to register the second highest CAGR during the report’s forecast period. The segment of reporter gene assays is also anticipated to register impressive growth over the forecast period.

Get Sample Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=550

Increasing demand for technologically advanced assay systems offering precise assays and wide sensitivity, large signal-to-background ratio, and linearity aids the growth of this segment. In terms of therapeutic segments, the global GPCRs market is segmented into central nervous system, cardiovascular system, immune system, respiratory system, oncology, and reproductive system. Of these, oncology emerged as the largest therapeutic segment of the global GPCRs market in 2013 and is anticipated to continue its lead over the forecast period.  Based on geography, the global GPCRs market is at present dominated by North America owing to the high awareness regarding advanced assays in the region and the high disposable income of people, allowing them to employ expensive equipment and machinery. Rising demand for advanced technology and high funding in R&D endeavors also aid the growth of the GPCRs market in North America. Apart from this, the rising geriatric population and accelerating incidence of obesity will augment the demand for GPCRs in the region. 

The global GPCRs market is segmented as follows:

GPCRs Market, by Assay Type

  • Calcium Level Detection Assays 
  • GTPγS Binding Assays 
  • cGMP Assays
  • Reporter Gene Assays 
  • Receptor Internalization Assay 
  • cAMP Assays 

GPCRs Market, by Therapeutic Area

  • Cardiovascular System
  • Central Nervous System
  • Respiratory System
  • Immune System
  • Reproductive System
  • Oncology
  • Others

GPCRs Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. 

CONTACT: Mr. Nachiket Ghumare
         90 Sate Street, Suite 700
         Albany, NY 12207
         Tel: +1-518-618-1030
         USA - Canada Toll Free: 866-552-3453
         Email: sales@transparencymarketresearch.com 
         Website: http://www.transparencymarketresearch.com